ARTICLE | Management Tracks
Karp, Ghosh depart Biogen; plus Exelixis, Senti, Applied Therapeutics, Oncopeptides, Acacia and more
March 4, 2020 1:31 AM UTC
Two senior executives at Biogen Inc. (NASDAQ:BIIB) have stepped down this past week: EVP of Corporate Development Daniel Karp and Anirvan Ghosh, SVP, head of research and early development. Ghosh will become CEO of cellular senescence company Unity Biotechnology Inc. (NASDAQ:UBX), effective March 30. He succeeds Keith Leonard, who is stepping down as CEO due to personal reasons while remaining chairman. Biogen did not disclose Karp’s next appointment.
Exelixis Inc. (NASDAQ:EXEL) said George Scangos will retire from the board. Scangos served as president and CEO of the cancer company in 1996-2010. He is now CEO of Vir Biotechnology Inc. (NASDAQ:VIR)...